Recruiting COPD Studies in Boston
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)
The purpose of this study is to determine if doxycycline will reduce progression of emphysema in people living with HIV. The secondary objectives are to examine the effects of doxycycline on change i...
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investi...
About COPD Clinical Trials in Boston
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes breathing difficult, primarily caused by smoking. It includes emphysema and chronic bronchitis. Treatment involves bronchodilators, inhaled steroids, pulmonary rehabilitation, and oxygen therapy.
There are currently 2 copd clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 376 participants. Research is being sponsored by Weill Medical College of Cornell University, VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.
COPD Clinical Trials in Boston — FAQ
Are there copd clinical trials in Boston?
Yes, there are 2 copd clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What copd treatments are being tested?
The 2 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for copd.
Data updated March 2, 2026 from ClinicalTrials.gov